Literature DB >> 1531702

Altered aspartate in Alzheimer neurofibrillary tangles.

I L Payan1, S J Chou, G H Fisher, E H Man, C Emory, W H Frey.   

Abstract

Normal protein-bound L-aspartyl/L-asparaginyl residues may undergo post-translational modification by racemization to D-aspartate, or by isomerization to the L-isoaspartyl form in which the peptide chain links through the beta carboxyl group of the residue. Based on preliminary results reported here, proteins associated with Alzheimer neurofibrillary tangle preparations contain a significantly greater number of these modified aspartyl residues than the unaffected proteins from the surrounding gray matter or in comparable preparations from normal brains.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531702     DOI: 10.1007/bf00966798

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  15 in total

1.  D-aspartic acid in purified myelin and myelin basic protein.

Authors:  G H Fisher; N M Garcia; I L Payan; R Cadilla-Perezrios; W A Sheremata; E H Man
Journal:  Biochem Biophys Res Commun       Date:  1986-03-13       Impact factor: 3.575

2.  Differential racemization of aspartate and serine in human myelin basic protein.

Authors:  R Shapira; C H Chou
Journal:  Biochem Biophys Res Commun       Date:  1987-08-14       Impact factor: 3.575

3.  Isolation of paired helical filaments and amyloid fibers from human brain.

Authors:  D J Selkoe; C R Abraham
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

Review 4.  Alzheimer's disease.

Authors:  R Katzman
Journal:  N Engl J Med       Date:  1986-04-10       Impact factor: 91.245

5.  Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins.

Authors:  R C Stephenson; S Clarke
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

6.  Synthetic peptide substrates for the erythrocyte protein carboxyl methyltransferase. Detection of a new site of methylation at isomerized L-aspartyl residues.

Authors:  E D Murray; S Clarke
Journal:  J Biol Chem       Date:  1984-09-10       Impact factor: 5.157

7.  Racemized D-aspartate in Alzheimer neurofibrillary tangles.

Authors:  G H Fisher; I L Payan; S J Chou; E H Man; S Cerwinski; T Martin; C Emory; W H Frey
Journal:  Brain Res Bull       Date:  1992-01       Impact factor: 4.077

8.  Accumulation of D-aspartic acid with age in the human brain.

Authors:  E H Man; M E Sandhouse; J Burg; G H Fisher
Journal:  Science       Date:  1983-06-24       Impact factor: 47.728

9.  Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition.

Authors:  K Iqbal; T Zaidi; C H Thompson; P A Merz; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

10.  Neuritic plaque amyloid in Alzheimer's disease is highly racemized.

Authors:  R Shapira; G E Austin; S S Mirra
Journal:  J Neurochem       Date:  1988-01       Impact factor: 5.372

View more
  8 in total

1.  Are ancient proteins responsible for the age-related decline in health and fitness?

Authors:  Roger John Willis Truscott
Journal:  Rejuvenation Res       Date:  2010-02       Impact factor: 4.663

2.  Quantification of D-amino acids in human urine using GC-MS and HPLC.

Authors:  H Brückner; S Haasmann; A Friedrich
Journal:  Amino Acids       Date:  1994-06       Impact factor: 3.520

3.  Advanced Maillard reaction end products are associated with Alzheimer disease pathology.

Authors:  M A Smith; S Taneda; P L Richey; S Miyata; S D Yan; D Stern; L M Sayre; V M Monnier; G Perry
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

4.  Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer's Disease.

Authors:  Evan E Hubbard; Lilian R Heil; Gennifer E Merrihew; Jasmeer P Chhatwal; Martin R Farlow; Catriona A McLean; Bernardino Ghetti; Kathy L Newell; Matthew P Frosch; Randall J Bateman; Eric B Larson; C Dirk Keene; Richard J Perrin; Thomas J Montine; Michael J MacCoss; Ryan R Julian
Journal:  J Proteome Res       Date:  2021-11-24       Impact factor: 4.466

Review 5.  Novel aspects of macromolecular repair and relationship to human disease.

Authors:  Hans E Krokan; Bodil Kavli; Geir Slupphaug
Journal:  J Mol Med (Berl)       Date:  2004-02-24       Impact factor: 4.599

6.  Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration.

Authors:  Jerzy Wegiel; Izabela Kuchna; Krzysztof Nowicki; Janusz Frackowiak; Bozena Mazur-Kolecka; Humi Imaki; Jarek Wegiel; Pankaj D Mehta; Wayne P Silverman; Barry Reisberg; Mony Deleon; Thomas Wisniewski; Tuula Pirttilla; Harry Frey; Terho Lehtimäki; Tarmo Kivimäki; Frank E Visser; Wouter Kamphorst; Anna Potempska; David Bolton; Julia R Currie; David L Miller
Journal:  Acta Neuropathol       Date:  2007-01-20       Impact factor: 17.088

7.  Metabolomics profiling reveals differential adaptation of major energy metabolism pathways associated with autophagy upon oxygen and glucose reduction.

Authors:  Katja Weckmann; Philip Diefenthäler; Marius W Baeken; Kamran Yusifli; Christoph W Turck; John M Asara; Christian Behl; Parvana Hajieva
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

8.  Chronic NMDA receptor stimulation: therapeutic implications of its effect on adenosine A1 receptors.

Authors:  D K Von Lubitz; J Kim; M Beenhakker; M F Carter; R C Lin; Y Meshulam; J W Daly; D Shi; L M Zhou; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1995-09-05       Impact factor: 4.432

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.